Table 3 Summary of treatment scenarios included in the cervical precancer planning tool (CPPT)

1

Single-visit approach (SVA) for screen and treat

90%

Treatment is available at all health centers and higher-level facilities (excludes health posts). Women receive screening and treatment in one visit. Assumes 10% of women will refuse treatment.

2

Hospital treatment

70%

Treatment is only available at hospitals. If a woman is screened at a health center, she will need to travel to a hospital for a second patient visit to receive treatment. Assumes 30% of women will not go back for a second visit for treatment at a hospital.

3

District treatment

60%

Treatment is only available at select district hospitals. A minimum of one treatment device is placed per district. Additional devices are placed in districts with greater demands. Assumes 40% of women will not travel for a second visit at a hospital in their district for treatment.

4

District clustering

50–60%

Treatment is only available at select district hospitals. Up to two districts with lower demand can share one treatment device. Additional treatment devices are placed in districts with greater demand. If two districts are sharing one treatment device, assumes 50% of women will not travel for a second visit at a hospital in a neighboring district for treatment. If the treatment device is located in the woman’s district, assumes same as Scenario 3.

5

Hybrid static-mobile

80%

Treatment devices are based at select hospitals and treatment is available at these hospitals as well as delivered by mobile units from hospitals to screening sites (health centers or above). Assumes that 20% of women will not go back to a hospital or their local screening site for a second visit for treatment.